- Home
- Endocrinology
- SURPASS-5 Trial: Subcutaneous Tirzepatide Vs Placebo Added to Titrated Insulin Glargine

20224 min read
Medical Article
Today physicians providing care for patients with type 2 diabetes have numerous alternatives available in the armamentarium. It has been that during the brief visit of the patient, in most cases the clinicians most likely advocate for healthier lifestyle choices and only then consider prescribing medication. They focus on patterns of glycemia and t

SURPASS-5 Trial: Subcutaneous Tirzepatide Vs Placebo Added to Titrated Insulin Glargine
Similar Content

Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes

Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Resistant Thyrotoxicosis in Pregnancy
1332 Reached4 Comments2 Likes

Pancytopenia, a rare presentation of hyperthyroidism
825 Reached2 Comments